Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Update

$Seres Therapeutics(MCRB.US)$ Press Release: Seres Therapeutics Enters Into Memorandum of Understanding For Vowst(TM) Asset Sale to Nestlé Health Science
Dow Jones· 4 mins ago
CAMBRIDGE, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that it has entered into a non-binding memorandum of understanding with Nestlé Health Science for the sale of Seres' VOWST assets that will provide Nestlé Health Science with full VOWST product and related intellectual property rights. Under the terms of the pending agreement, Seres is due to receive capital infusions, including an upfront payment. Seres expects to complete the transaction within the next 90 days, subject to the negotiation of definitive agreements, Seres' shareholder approval, and other customary conditions.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
5
Translate
Report
4840 Views
Comment
Sign in to post a comment
2557Followers
28Following
34KVisitors
Follow